1,946
Views
1
CrossRef citations to date
0
Altmetric
Articles

Long term follow-up of uterine fibroids treated with microwave ablation: an up to 3-year observational study of volume, regrowth, and symptoms

, , , & ORCID Icon
Pages 1158-1163 | Received 02 May 2022, Accepted 31 Jul 2022, Published online: 01 Sep 2022

References

  • Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014;6:95–114.
  • Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016;22(6):665–686.
  • Aarts JWM, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;2015(8):Cd003677.
  • Clayton RD. Hysterectomy. Best Pract Res Clin Obstet Gynaecol. 2006;20(1):73–87.
  • Arellano RS. What's new in percutaneous ablative strategies for hepatocellular carcinoma and colorectal hepatic metastases? 2020 update. Curr Oncol Rep. 2020;22(10):105.
  • Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24(10):e990–e1005.
  • Shakeri S, Raman SS. Trends in percutaneous thermal ablation therapies in the treatment of T1a renal cell carcinomas rather than partial nephrectomy/radical nephrectomy. Semin Intervent Radiol. 2019;36(3):183–193.
  • Zhang J, Feng L, Zhang B, et al. Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment–a clinical study. Int J Hyperthermia. 2011;27(5):510–516.
  • Liu H, Zhang J, Han Z-Y, et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Int J Hyperthermia. 2016;32(8):876–880.
  • Xia M, Jing Z, Zhi-Yu H, et al. Feasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRI. Br J Radiol. 2014;87(1040):20130770.
  • Jonsdottir G, Beermann M, Lundgren Cronsioe A, et al. Ultrasound guided microwave ablation compared to uterine artery embolization treatment for uterine fibroids: a randomized controlled trial. Int J Hyperthermia. 2022;39(1):341–347.
  • Wise LA, Laughlin-Tommaso SK. Epidemiology of uterine fibroids: from menarche to menopause. Clin Obstet Gynecol. 2016;59(1):2–24.
  • Coyne KS, Margolis MK, Murphy J, et al. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Value Health. 2012;15(5):674–679.
  • Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99(2):290–300.
  • Magnay JL, O'Brien S, Gerlinger C, et al. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20(1):24.
  • Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG. 2000;107(3):320–322.
  • Gomez E, Nguyen M-LT, Fursevich D, et al. MRI-based pictorial review of the FIGO classification system for uterine fibroids. Abdom Radiol (NY). 2021;46(5):2146–2155.